Abstract
We recently reported that transrectal or intestinal portal scintigraphy with123I-iodoamphetamine (IMP) could be a useful method for the non-invasive and quantitative evaluation of the portosystemic shunt in portal hypertension, but what cells in the liver trap IMP has not been clarified. This study was aimed at elucidating whether IMP was extracted by parenchymal cells, sinusoidal endothelial cells, Kupffer cells or fat storing cells. Each type of liver cell was isolated from rats and cultured. The cells were incubated with125I-IMP and the radioactivity of the lysate was determined. Nonspecific binding was assessed in the presence of an excess of unlabeled IMP, and specific binding was determined by subtracting the nonspecific from total binding. Specific binding observed in parenchymal cells, endothelial cells and Kupffer cells was 70.2 ± 0.4, 4.2 ± 1.4 and 2.3 ±0.8 pmol/well, respectively, but no specific binding was observed in fat storing cells. The binding in parenchymal cells was much higher than that in endothelial cells or Kupffer cells (p < 0.005). In addition, the binding to parenchymal cells reached equilibrium within 20 min and was not saturable over the concentration range tested (0.5–10 μM). These findings indicate that IMP is mostly extracted by parenchymal cells in the liver.
Similar content being viewed by others
References
Kuhl DE, Barrio JR, Huang S-C, Selin C, Ackermann RF, Lear JL, et al. Quantifying local cerebral blood flow by Nisopropyl-p-[I-123]iodoamphetamine (IMP) tomography.J Nucl Med 23: 196–203, 1982.
Lee RGL, Hill TC, Holman BL, Uren R, Clouse ME. Comparison of N-isopropyl(I-123)p-iodoamphetamine brain scans using Anger camera scintigraphy and single-photon emission tomography.Radiology 145: 789–793, 1982.
Van Zandwijk N, Zwijnenburg A, Hoefnagel CA, Marcuse HR. N-isopropyl-p[I-123]iodoamphetamine, a new agent for lung imaging studies.Thorax 41: 801–803, 1986.
Nakajo M, Uchiyama N, Hiraki Y, Miyata Y, Iriki A, Hirotsu Y, et al. Increased accumulation of iodine-123-IMP in the pulmonary inflammatory lesion surrounding a lung cancer.Ann Nucl Med 2: 49–53, 1988.
Nakajo M, Uchiyama N, Shimada J, Shinohara S, Iriki A, Hirotsu Y, et al. Differentiation of bronchogenic carcinoma from secondary changes, obstructive pneumonitis and/or collapse by I-123 IMP lung imaging.Ann Nucl Med 4: 1–13, 1990.
Yen CK, Pollycove M, Crass R, Lin TH, Baldwin R, Lamb J. Portosystemic shunt fraction quantification with colonic iodine-123 iodoamphetamine.J Nucl Med 27: 1321–1326, 1986.
Kashiwagi T, Azuma M, Ikawa T, Takehara T, Matsuda H, Yoshioka H, et al. Portosystemic shunting in portal hypertension: evaluation with portal scintigraphy with transrectally administered I-123 IMP.Radiology 169: 137–140, 1988.
Rahimian J, Glass EC, Touya JJ, Akber SF, Graham LS, Bennett LR. Measurement of metabolic extraction of tracers in the lung using a multiple indicator dilution technique.J Nucl Med 25: 31–37, 1984.
Hijioka T, Rosenberg RL, Lemasters JJ, Thurman RG. Kupffer cells contain voltage-dependent calcium channels.Mol Pharmacol 41: 435–440, 1992.
Sleyster ECH, Westerhuis FG, Knook DL. The purification of nonparenchymal liver cell classes by centrifugal elutriation.In: Knook DL, Wisse E, eds. Sinusoidal Liver Cells. Amsterdam: Elsevier Biochemical, pp. 289–298, 1982.
Pertoft H, Smedsrod B. Separation and characterization of liver cells.In: Pretlow II TG, Pretlow TP, eds. Cell Separation; Methods and Selected Applications. Vol. 4. New York: Academic Press, pp. 1–24, 1987.
Nagelkerke JF, Barto KP, van Berkel T-JC.In vivo andin vitro uptake and degradation of acetylated low density lipoprotein by rat liver endothelial, Kupffer, and parenchymal cells.J Biol Chem 258: 12221–12227, 1983.
Doolittle M, Bohman R, Durstenfeld A, Cascarano J, Identification and characterization of liver nonparenchymal cells by flow cytometry.Hepatology 7: 696–703, 1987.
Touya JJ, Rahimian J, Grubbs DE, Corbus HF, Bennett R. A noninvasive procedure forin vivo assay of a ling amine endothelial receptor.J Nucl Med 26: 1302–1307, 1985.
Kosuda S, Kawahara S, Ishibashi A, Tamura K, Kubo A, Hashimoto S. Experimental study of N-isopropyl-p-iodoamphetamine lung uptake.KAKU IGAKU (Jpn J Nucl Med) 27: 149–153, 1990.
Ito T, Sasaki Y, Hayashi N, Sato N, Kamada T, Kashiwagi T, et al. Determination of intrahepatic distribution of IMP by microautoradiography (abstr).KAKU IGAKU (Jpn J Nucl Med) 26: 1053, 1989.
Tanaka E, Mishima M, Kawakami K, Sakai N, Sugiura N, Taniguchi T, et al. N-isopropyl-p-iodoamphetamine receptors in normal and cancerous tissue of the lung.Eur J Nucl Med 20: 293–296, 1993.
Mori H, Shiba K, Tsuji S, Matsuda H, Hisada K. Binding sites and subcellular distribution of N-isopropyl-p-(I-125)iodoamphetamine in the rat brain.KAKU IGAKU (Jpn J Nucl Med) 23: 1585–1594, 1986.
Kosuda S, Kawahara S, Ishibashi A, Tamura K, Kubo A, Hashimoto S. Experimental study on liver accumulation of N-isopropyl-p-iodoamphetamine.KAKU IGAKU (Jpn J Nucl Med) 27: 599–605, 1990.
Howlett DR, Nahorski SR. Quantitative assessment of heterogenous H—spiperone binding to rat neostriatum and frontal cortex.Life Sciences 26: 511–517, 1980.
Mousseau DD, Layrargues GP, Butterworth RF. Region-selective decreases in densities of [3H]tryptamine binding sites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy.J Neurochem 62: 621–625, 1994.
Joulin Y, Moretti JL, Hoellinger H, Defer G. Fate of isopropyl-iodoamphetamine (IMP) in rat liver microsomes.Nucl Med Commun 13: 99–105, 1992.
Meredith MJ. Rat hepatocytes prepared without collagenase: Prolonged retention of differentiated characteristics in culture.Cell Biol & Toxicol 4: 405–425, 1988.
Fukui H, Kashiwagi T, Kasahara T, Takei Y, Hijioka T, Goto M, et al. Evaluation of effective portal venous flow in chronic liver diseases using echo-Doppler flowmetry combined with per jejunal portal scintigraphy.J Nucl Med 34: 1103–1108, 1993.
Kashiwagi T, Fukui H, Kozuka T, Goto M, Takei Y, Kasahara A, et al. Assessment of portosystemic shunting from superior mesentric vein by duodenal administration of I-123 iodoamphetamine.Eur J Nucl Med 19: 181–185, 1992.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hijioka, T., Kashiwagi, T., Ito, T. et al. Binding cells of125I-iodoamphetamine in rat liver. Ann Nucl Med 11, 27–32 (1997). https://doi.org/10.1007/BF03164754
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03164754